Lv3
318 积分 2024-10-29 加入
Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study
1个月前
已完结
Asundexian versus Apixaban in Patients with Atrial Fibrillation
2个月前
已完结
Pharmacokinetics, pharmacodynamics and safety profile of SKB336, a selective inhibitor of coagulation factor XI/XIa in healthy subjects
2个月前
已完结
Efficacy and safety of REGN9933A2 and REGN7508Cat for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trials
2个月前
已完结
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis
2个月前
已完结
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
2个月前
已完结
AAVLINK: A potent DNA-recombination method for large cargo delivery in gene therapy
3个月前
已完结
Proceedings of the 2024 Classic Examples in Toxicologic Pathology XXXI
4个月前
已完结
RENAL-SELECTIVE DELIVERY AND ANGIOTENSIN-CONVERTING ENZYME INHIBITION BY SUBCUTANEOUSLY ADMINISTERED CAPTOPRIL-LYSOZYME
4个月前
已关闭
Prediction of Interspecies Translation for Targeting Delivery Coefficients of GalNAc-siRNA Silencing Apolipoprotein C-III Using a Mechanistic Minimal Physiologically Based Pharmacokinetic/Pharmacodynamic Model
4个月前
已完结
皖公网安备34019202002308
